Login / Signup

Ceftazidime/Avibactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Infection in Lung Transplant Recipients.

Juan ChenQiqiang LiangShuo DingYongshan XuYanting HuJingyu ChenMan Huang
Published in: Infection and drug resistance (2023)
CAZ/AVI may be an alternative and promising regimen for CRPA eradiation in lung transplant recipients.
Keyphrases
  • pseudomonas aeruginosa
  • gram negative
  • cystic fibrosis
  • klebsiella pneumoniae
  • drug resistant
  • smoking cessation